Cargando…
Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations
The preclinical safety assessment of novel nanotechnology-based drug products frequently relies on in vitro assays, especially during the early stages of product development, due to the limited quantities of nanomaterials available for such studies. The majority of immunological tests require donor...
Autores principales: | Cedrone, Edward, Neun, Barry W., Rodriguez, Jamie, Vermilya, Alison, Clogston, Jeffrey D., McNeil, Scott E., Barenholz, Yechezkel, Szebeni, Janos, Dobrovolskaia, Marina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943954/ https://www.ncbi.nlm.nih.gov/pubmed/29267243 http://dx.doi.org/10.3390/molecules23010012 |
Ejemplares similares
-
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
por: Neun, Barry W., et al.
Publicado: (2018) -
Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
por: Newton, Hannah S., et al.
Publicado: (2023) -
Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations
por: Neun, Barry W., et al.
Publicado: (2020) -
Roadmap and strategy for overcoming infusion reactions to nanomedicines
por: Szebeni, Janos, et al.
Publicado: (2018) -
Chemical Modification of CRISPR gRNAs Eliminate type I Interferon Responses in Human Peripheral Blood Mononuclear Cells
por: Schubert, Mollie S., et al.
Publicado: (2018)